Evidence map›Paper›PMID 37636233›Full record

ArticleMovement disorders clinical practice2023

Meropenem-Induced Facial Myoclonus.

Patricio Millar Vernetti, Kaia Dalamo, Zenith Khan, Alejandra Gonzalez-Duarte, Steven Frucht, Horacio Kaufmann

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Movement disorders clinical practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Preface to the 4th MDS Video Challenge Case Supplement forMovement disorders clinical practice · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Patricio Millar VernettiDepartment of Neurology, Dysautonomia Center New York University School of Medicine New York New York USA.
Kaia DalamoDepartment of Neurology, Dysautonomia Center New York University School of Medicine New York New York USA.
Zenith KhanDepartment of Neurology, Dysautonomia Center New York University School of Medicine New York New York USA.
Alejandra Gonzalez-DuarteDepartment of Neurology, Dysautonomia Center New York University School of Medicine New York New York USA.
Steven FruchtDepartment of Neurology Fresco Institute for Parkinson's and Movement Disorders New York University Grossman School of Medicine New York New York USA.
Horacio KaufmannDepartment of Neurology, Dysautonomia Center New York University School of Medicine New York New York USA.
Dysautonomia Foundation · USNew York University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

carbapenemsmyoclonusneurotoxicity

Identifiers

PMID37636233
PMCPMC10448627
OpenAlexW4386143020

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.